TG Therapeutics TGTX Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's operating income?
- TG Therapeutics (TGTX) reported operating income of $34.8M in Q1 2026.
- How has TG Therapeutics's operating income changed year-over-year?
- TG Therapeutics's operating income increased by 303.6% year-over-year, from $8.62M to $34.8M.
- What is the long-term trend for TG Therapeutics's operating income?
- Over 3 years (2021 to 2025), TG Therapeutics's operating income has grown at a -29.0% compound annual growth rate (CAGR), from -$344.77M to $123.32M.
- What does operating income mean?
- Profit earned from core business operations before interest and taxes.
- How do you interpret operating income?
- An increase indicates improved operational efficiency or higher sales volume, while a decrease suggests rising costs or weakening demand.
- How does operating income compare across companies?
- A primary benchmark for comparing the core profitability of companies within the same industry.